All Cosmos Bio-Tech Holding Corp. Statistics
All Cosmos Bio-Tech Holding Corp. (4148) Stock Statistics & Valuation Metrics
Total Valuation
All Cosmos Bio-Tech Holding Corp. has a market cap or net worth of TWD 1.89B. The enterprise value is TWD 1.96B.
- Market Cap
- TWD 1.89B
- Enterprise Value
- TWD 1.96B
Share Statistics
All Cosmos Bio-Tech Holding Corp. has 67,235,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 67,235,700
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
All Cosmos Bio-Tech Holding Corp.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.32%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 5.32%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 8.01M
- Profits Per Employee
- 415.76K
- Employee Count
- 368
- Asset Turnover
- 0.70
- Inventory Turnover
- 3.10
Valuation Ratios
The current PE Ratio of All Cosmos Bio-Tech Holding Corp. is 10.44. All Cosmos Bio-Tech Holding Corp.’s PEG ratio is 0.39.
- PE Ratio
- 10.44
- PS Ratio
- 0.61
- PB Ratio
- 0.85
- Price to FCF
- 10.38
- Price to Operating Cash Flow
- 10.79
- PEG Ratio
- 0.39
Income Statement
In the last 12 months, All Cosmos Bio-Tech Holding Corp. had revenue of 2.95B and earned 153.00M in profits. Earnings per share was 2.28.
- Revenue
- 2.95B
- Gross Profit
- 829.47M
- Operating Income
- 296.59M
- Pretax Income
- 297.37M
- Net Income
- 153.00M
- EBITDA
- 362.56M
- Earnings Per Share (EPS)
- 2.28
Cash Flow
In the last 12 months, operating cash flow was 219.52M and capital expenditures -32.99M, giving a free cash flow of 186.53M billion.
- Operating Cash Flow
- 219.52M
- Free Cash Flow
- 186.53M
- Free Cash Flow per Share
- 2.27
Dividends & Yields
All Cosmos Bio-Tech Holding Corp. pays an annual dividend of ―, resulting in a dividend yield of 3.57%
- Dividend Per Share
- ―
- Dividend Yield
- 3.57%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 9.63%
- Earnings Yield
- 7.84%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- -27.14%
- 50-Day Moving Average
- 31.57
- 200-Day Moving Average
- 33.41
- Relative Strength Index (RSI)
- 21.31
- Average Volume (3m)
- 50.14K
Important Dates
All Cosmos Bio-Tech Holding Corp. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
All Cosmos Bio-Tech Holding Corp. as a current ratio of 4.99, with Debt / Equity ratio of 13.90%
- Current Ratio
- 4.99
- Quick Ratio
- 3.88
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- -2.33
- Interest Coverage Ratio
- 20.41
Taxes
In the past 12 months, All Cosmos Bio-Tech Holding Corp. has paid 91.14M in taxes.
- Income Tax
- 91.14M
- Effective Tax Rate
- 0.31
Enterprise Valuation
All Cosmos Bio-Tech Holding Corp. EV to EBITDA ratio is 3.57, with an EV/FCF ratio of 7.54.
- EV to Sales
- 0.44
- EV to EBITDA
- 3.57
- EV to Free Cash Flow
- 7.54
- EV to Operating Cash Flow
- 6.41
Balance Sheet
All Cosmos Bio-Tech Holding Corp. has TWD 1.42B in cash and marketable securities with TWD 612.75M in debt, giving a net cash position of TWD 806.68M billion.
- Cash & Marketable Securities
- TWD 1.42B
- Total Debt
- TWD 612.75M
- Net Cash
- TWD 806.68M
- Net Cash Per Share
- TWD 12.00
- Tangible Book Value Per Share
- TWD 42.46
Margins
Gross margin is 28.28%, with operating margin of 10.27%, and net profit margin of 5.85%.
- Gross Margin
- 28.28%
- Operating Margin
- 10.27%
- Pretax Margin
- 10.94%
- Net Profit Margin
- 5.85%
- EBITDA Margin
- 12.42%
- EBIT Margin
- 10.31%
Analyst Forecast
The average price target for All Cosmos Bio-Tech Holding Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 15.66%
- EPS Growth Forecast
- 31.51%
